Company:  AMYLIN PHARMACEUTICALS IN ...
Form Type:  CT ORDER
Filing Date:  4/12/2012 
CIK:  0000881464 
Address:  9360 TOWNE CENTRE DR
SUITE 110
 
City, State, Zip:  SAN DIEGO, California 92121 
Telephone:  (619) 552-2200 
Fiscal Year:  12/31 
Description of Business
We are a biopharmaceutical company committed to improving the lives of people with diabetes, obesity and other metabolic diseases through the discovery, development and commercialization of innovative medicines. We are marketing two first-in-class medicines to treat diabetes, BYETTA� (exenatide) injection and SYMLIN� (pramlintide acetate) injection and we are currently seeking approval for BYDUREON� (exenatide extended-release for injectable suspension), an investigational sustained-release medication for type 2 diabetes that is administered only once a week.
Register and access this filing in: